Search for: "Boehringer-Ingelheim" Results 81 - 100 of 443
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
18 Jul 2006, 7:26 am
The drug, manufactured by Boehringer Ingelheim Pharmaceuticals, imitates the effect of dopamine. [read post]
16 Feb 2014, 11:16 am
Boehringer Ingelheim says the drug was proven through clinical trials and that the FDA confirms it safety. [read post]
26 Feb 2016, 7:20 am by Tom Lamb
These SGLT2 drugs are currently approved for use by patients in the US: Invokana (canagliflozin) — Janssen Pharmaceuticals — FDA Approval: 2013 Invokamet (canagliflozin and metformin) — Janssen Pharmaceuticals — FDA Approval: 2014 Farxiga (dapagliflozin) — AstraZeneca Pharmaceuticals — FDA Approval: 2014 Xigduo XR (dapagliflozin and metformin extended-release) — AstraZeneca Pharmaceuticals — FDA Approval: 2014 Jardiance (empagliflozin) —… [read post]
9 Mar 2015, 11:12 pm
Pradaxa is an oral anticoagulant similar to Xarelto and Eliquis, which has been prescribed to patients with a serious medical condition known as atrial fibrillation (Afib) as an alternative to Warfarin and other traditional blood thinning agents. [read post]
6 Aug 2020, 5:36 am by Jonathan Rosenfeld
The Zantac lawsuits that are in federal court are now part of multi-district litigation against Sanofi and Boehringer Ingelheim. [read post]
28 Oct 2012, 6:37 pm
Boehringer Ingelheim Pharmaceuticals Inc., a Germany-based pharmaceutical company that markets and sells drugs in the United States, has recently agreed to settle claims that it illegally promoted four of its best-selling drugs for $95 million. [read post]
1 Aug 2008, 3:43 pm
Yet another installment in Boehringer Ingelheim v Swingward and friends (and it's not the last one either). [read post]
8 Jul 2012, 9:13 pm by Patent Docs
.; Boehringer Ingelheim Roxane, Inc. [read post]
31 May 2010, 8:52 pm by Patent Docs
Intervet Inc. et al. 1:10-cv-00435; filed May 25, 2010 in the District Court of Delaware • Plaintiff: Wyeth LLC • Defendants: Intervet Inc. d/b/a Intervet/Schering-Plough Animal Health; Boehringer Ingelheim Vetmedica Inc. [read post]
15 Dec 2008, 4:38 am
Boehringer Ingelheim Vetmedica, Inc.3:08-cv-00116; filed December 8, 2008 in the Middle District of GeorgiaThe complaints in these cases are substantially identical. [read post]
19 Jan 2017, 7:17 am by Robert Kraft
Fierce Pharma reported on a study published in JAMA showing that Johnson & Johnson and Bayer’s Xarelto (rivaroxaban) may cause more serious bleeding than Boehringer Ingelheim’s Pradaxa (dabigatran). [read post]
25 Oct 2009, 8:54 pm
Intervet Inc. et al. 1:09-cv-00780; filed October 20, 2009 in the District Court of Delaware • Plaintiff: Wyeth • Defendants: Intervet Inc. d/b/a Intervet/Schering-Plough Animal Health; Boehringer Ingelheim Vetmedica Inc. [read post]
2 Apr 2012, 7:33 am by Legal Intern
The potential for Boehringer Ingelheim's Pradaxa to cause serious bleeding events in patients has been a serious cause for concern in patients taking the blood thinner. [read post]
5 Aug 2016, 2:10 pm by Tom Lamb
Current Product Liability Litigation Cases Which Involve Popular Drugs With Serious Side Effects That Are Starting To Gain More Attention   (Posted by Tom Lamb at DrugInjuryWatch.com)   This article will feature three types of drug injury cases that are starting to gain some momentum in terms of the number of lawsuits filed against the responsible pharmaceutical companies in courts across the country. (1) Diabetes Medicines in the Sodium-Glucose Co-Transporter-2 (SGLT2) Inhibitors Class of… [read post]
16 Jan 2013, 9:50 am
Many injured patients have filed a Pradaxa lawsuit against Boehringer Ingelheim, the manufacturer of Pradaxa. [read post]
23 Dec 2012, 12:53 am
Pradaxa Serious and Deadly Side Effects Boehringer Ingelheim, the German manufacturer of Pradaxa faces more than 120 Pradaxa lawsuits. [read post]